ssrx posts

Feed

Analyst initiations: WYE, SSRX, CEL and PTNR

MOST NOTEWORTHY: Wyeth, 3SBio Inc, Cellcom Israel and Partner Communications were today's noteworthy initiations:
  • Citigroup initiated Wyeth (NYSE: WYE) with a Hold rating and $49 target. The firm believes the upside potential from bapineuzumab is masking the company's unfavorable average EPS and revenue growth forecast versus the industry.
  • Piper believes 3SBio Inc (NASDAQ: SSRX) is the market leader in a largely underpenetrated EPO market in China and sees limited downside risk. Shares were assumed with a Buy rating and $12 target.
  • RBC Capital initiated Cellcom Israel (NYSE: CEL) and Partner Communications (NASDAQ: PTNR) with Outperform ratings and targets of $40 and $30, respectively. RBC said they have defensive appeal given their predictable earnings stream.
OTHER INITIATIONS:

Analyst initiations 3-19-07: CVS Corp reinstated at JP Morgan & Credit Suisse

MOST NOTEWORTHY: CVS Corp (CVS), Express Scripts, Inc (ESRX) and Goodrich Petroleum Corp (GDP) were some of today's more notable initiations:
  • CVS Corp (NYSE: CVS) was reinstated at Credit Suisse with an Outperform and at JP Morgan with Neutral ratings.
  • Express Scripts (NASDAQ: ESRX) was reinstated at Credit Suisse with an Outperform rating, up from its Neutral rating, and resumed at Bank of America with a Buy rating. JP Morgan reinstated Express Scripts share with an Overweight rating.
  • Goodrich Petroleum (NYSE: GDP) was initiated with an Overweight rating at JP Morgan.
OTHER INITIATIONS:
  • Jefferies initiated Cellcom Israel Ltd (NYSE: CEL) with a Buy rating and $21 target.
  • CIBC initiated 3SBio Inc (NASDAQ: SSRX) with a Sector Outperformer rating and $17 target; the firm said 3SBio Inc offers the broadest range of BioGenerics in the Chinese market and views the company as an execution story and country play.
  • Cowen started G-III Apparel Group, Ltd (NASDAQ: GIII) with an Outperform rating based on expectations of market share growth to be driven by new brands and products.
  • BMO Capital Markets expects Riverbed Technology, Inc (NASDAQ: RVBD) with a Market Perform rating.
  • Lazard started Synta Pharmaceuticals Corp (NASDAQ: SNTA) with a Buy rating; Bear Stearns initiated shares of Synta with an Outperform rating.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Symbol Lookup
IndexesChangePrice
DJIA+72.8112,874.04
NASDAQ+27.512,931.39
S&P 500+9.131,351.77

Last updated: February 13, 2012: 05:15 PM

Hot Stocks

General Electric

19.07+0.195(+1.03)

Alcoa

10.33+0.04(+0.39)

Apple Inc

502.60+9.18(+1.86)

Google Inc 'A'

612.20+6.29(+1.04)

Bank of America

8.25+0.18(+2.23)

Wal-Mart Stores

61.79-0.11(-0.18)

Exxon Mobil Corp

84.42+0.62(+0.74)

Ford

12.54+0.10(+0.80)

Citigroup

32.88-0.045(-0.14)

IBM

192.62+0.20(+0.10)

Yahoo

16.12-0.02(-0.12)

Starbucks

49.25+0.43(+0.88)

Microsoft

30.58+0.085(+0.28)

Home Depot

45.93+0.60(+1.32)

DailyFinance Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

Page Loaded in 1329171328584 ms.